1. OC-0282 HDR brachytherapy Monotherapy for prostate cancer: a one-day schedule phase II trial acute toxicity. (April 2019) Authors: Jolicoeur, M.; Nguyen, T.V.; Derashodian, T.; Hill, E.; Mondat, M.; Nachabe, M.; Antebi, E.; Wakil, G.; Héliou, R. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PP-0121 HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial. (May 2021) Authors: Jolicoeur, M.; Derashodian, T.; Nguyen-Huynh, T.; de Castro Hillmann, E.; Berbiche, D.; Truchon, D.; Héliou, R.; Mondat, M. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗